Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	32.11	274.77	207.98
Graham Fair Price	11.42	2.16	1.94
PEG	54.37	4.84	-3.14
Price/Book	-6.99	3.19	3.43
Price/Cash Flow	14.44	-45.28	-52.93
Prices/Earnings	-23.93	111.39	146.43
Price/Sales	16.08	15.55	13.39
Price/FCF	14.44	-45.28	-52.93
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	56.29	0.16	0.10
Operating Margin	191.06	0.02	< 0.005
ROA	13.66	< 0.005	< 0.005
ROE	< 0.005	< 0.005	22.26
ROIC	< 0.005	< 0.005	51.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.20	0.21	-3.29
Dividends QOQ	0.14	0.08	-44.63
EBIT QOQ	-1.12	3.35	199.33
EPS QOQ	-0.47	0.23	-50.72
FCF QOQ	0.57	-0.10	-83.37
Revenue QOQ	0.06	-0.19	242.73
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.67	48.00	34.60
Days Sales Outstanding (DSO)	28.20	17.47	-38.06
Inventory Turnover	2.52	1.87	-25.70
Debt/Capitalization	0.53	0.57	8.20
Quick Ratio	0.53	0.68	27.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.33	5.37	0.76
Cash	1.87	2.72	45.18
Capex	-0.73	-0.40	45.70
Free Cash Flow	-0.35	-0.38	-9.54
Revenue	1.37	1.10	-19.26
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.70	0.91	29.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	37.58	55.94	48.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating